Persistence of immune responses induced by Ebola virus vaccines.
The recent devastating outbreak of Ebola virus disease led to the accelerated development of multiple candidate vaccines against this virus, with at least eight entering clinical trials in 2014–16.1 Direct evidence of 100% eff ectiveness against disease has been demonstrated for VSV-EBOV, a vaccine...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|